- Home
- MINA-USD vs KLTO Comparison
MINA-USD vs KLTO Comparison
Compare MINA-USD & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MINA-USD
- KLTO
- Stock Information
- Founded
- MINA-USD N/A
- KLTO 2019
- Country
- MINA-USD
- KLTO United States
- Employees
- MINA-USD N/A
- KLTO N/A
- Industry
- MINA-USD
- KLTO
- Sector
- MINA-USD
- KLTO
- Exchange
- MINA-USD
- KLTO NYSE
- Market Cap
- MINA-USD N/A
- KLTO 5.9M
- IPO Year
- MINA-USD N/A
- KLTO N/A
- Fundamental
- Price
- MINA-USD $0.17
- KLTO $1.00
- Analyst Decision
- MINA-USD
- KLTO
- Analyst Count
- MINA-USD 0
- KLTO 0
- Target Price
- MINA-USD N/A
- KLTO N/A
- AVG Volume (30 Days)
- MINA-USD N/A
- KLTO 91.0M
- Earning Date
- MINA-USD N/A
- KLTO 08-15-2025
- Dividend Yield
- MINA-USD N/A
- KLTO N/A
- EPS Growth
- MINA-USD N/A
- KLTO N/A
- EPS
- MINA-USD N/A
- KLTO N/A
- Revenue
- MINA-USD N/A
- KLTO N/A
- Revenue This Year
- MINA-USD N/A
- KLTO N/A
- Revenue Next Year
- MINA-USD N/A
- KLTO N/A
- P/E Ratio
- MINA-USD N/A
- KLTO N/A
- Revenue Growth
- MINA-USD N/A
- KLTO N/A
- 52 Week Low
- MINA-USD N/A
- KLTO $0.11
- 52 Week High
- MINA-USD N/A
- KLTO $3.91
- Technical
- Relative Strength Index (RSI)
- MINA-USD 40.85
- KLTO N/A
- Support Level
- MINA-USD $0.16
- KLTO N/A
- Resistance Level
- MINA-USD $0.17
- KLTO N/A
- Average True Range (ATR)
- MINA-USD 0.01
- KLTO 0.00
- MACD
- MINA-USD 0.00
- KLTO 0.00
- Stochastic Oscillator
- MINA-USD 59.69
- KLTO 0.00
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.